Home › Insufficienza cardiaca › Wisconsin › Milwaukee
Studi clinici su Insufficienza cardiaca a Milwaukee, WI
16 studi su Insufficienza cardiaca cercano partecipanti presso sedi a Milwaukee e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
ELEVATE-HFpEF Clinical Study
In reclutamento
- Froedtert Hospital, Milwaukee
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
In reclutamentoFase 3
- ProHealth Care Research Institute and Cardiology Associates, Waukesha · a 17 mi di distanza
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
In reclutamentoFase 3
- Medical College of Wisconsin / Froedtert Hospital, Milwaukee
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
In reclutamentoFase 3
- Advocate Aurora Saint Lukes Medical Center, Milwaukee
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
In reclutamentoFase 3
- Milwaukee, WI Investigative Site 10061, Milwaukee
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
In reclutamento
- Aurora St. Luke's Medical Center, Milwaukee
Peripheral Venous Pressure (PVP) Trial
In reclutamento
- Aurora St. Luke's Medical Center, Milwaukee
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
In reclutamentoFase 2
- Froedtert Hospital - Center for Advanced Care, Milwaukee
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
In reclutamentoStudio osservazionale
- Milwaukee, Milwaukee
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
In reclutamentoStudio osservazionale
- Medical College of Wisconsin, Inc (PI Address), Milwaukee
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
In reclutamentoFase 3
- Aurora St. Luke's Medi Ctr, Milwaukee
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
In reclutamentoFase 3
- Milwaukee, WI Investigative Site FIN-10428, Milwaukee
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
In reclutamento
- Advocate Aurora St. Luke's, Milwaukee
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
In reclutamento
- Aurora Medical Group, Milwaukee
CCM OPEN HF Registry
In reclutamentoStudio osservazionale
- Advocate Aurora Health-St. Lukes, Milwaukee
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
In reclutamento
- Advocate Aurora Research Institute, Milwaukee
Studi su Insufficienza cardiaca in altre città
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Kansas City, MO25 studi
- Atlanta, GA25 studi
Altri studi a Milwaukee
- Cancro al seno23 studi
- Cancro del polmone non a piccole cellule22 studi
- Cancro (tutti i tipi)22 studi
- Cancro ai polmoni21 studi
- Mieloma multiplo21 studi
- Cancro alla prostata20 studi
- Linfoma follicolare19 studi
- Cancro pancreatico18 studi
- Linfoma non Hodgkin18 studi
- Cancro ovarico17 studi
- Leucemia mieloide acuta17 studi
- Linfoma di Burkitt16 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.